Beijing Tiantan Biological Products Corp Ltd
SSE:600161

Watchlist Manager
Beijing Tiantan Biological Products Corp Ltd Logo
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Watchlist
Price: 20.52 CNY -1.2% Market Closed
Market Cap: 40.6B CNY
Have any thoughts about
Beijing Tiantan Biological Products Corp Ltd?
Write Note

Relative Value

The Relative Value of one Beijing Tiantan Biological Products Corp Ltd stock under the Base Case scenario is 31.47 CNY. Compared to the current market price of 20.52 CNY, Beijing Tiantan Biological Products Corp Ltd is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
31.47 CNY
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
46
Median 3Y
9.1
Median 5Y
9.4
Industry
7.6
Forward
6.8
vs History
98
vs Industry
4
Median 3Y
44.3
Median 5Y
46.7
Industry
22.1
Forward
29.5
vs History
58
vs Industry
8
Median 3Y
30.3
Median 5Y
34
Industry
21.9
vs History
12
vs Industry
4
Median 3Y
41.5
Median 5Y
46.5
Industry
23.4
vs History
87
vs Industry
17
Median 3Y
4.8
Median 5Y
5.3
Industry
2.5
vs History
79
vs Industry
39
Median 3Y
8.6
Median 5Y
8.8
Industry
7.5
Forward
6.2
vs History
95
vs Industry
26
Median 3Y
17.3
Median 5Y
18.1
Industry
9.3
vs History
98
vs Industry
4
Median 3Y
26.7
Median 5Y
28.5
Industry
4.2
Forward
15.3
vs History
98
vs Industry
5
Median 3Y
26.7
Median 5Y
28.5
Industry
4
Forward
23.7
vs History
63
vs Industry
8
Median 3Y
27.4
Median 5Y
31.8
Industry
5.9
vs History
23
vs Industry
4
Median 3Y
36.7
Median 5Y
39.9
Industry
3.9
vs History
93
vs Industry
33
Median 3Y
4
Median 5Y
4.7
Industry
4.5

Multiples Across Competitors

Competitors Multiples
Beijing Tiantan Biological Products Corp Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
40.6B CNY 7.8 31.8 18.5 18.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7 -180 740.1 -219 476 -216 971.5
US
Abbvie Inc
NYSE:ABBV
310.2B USD 5.6 61.1 15.2 23.4
US
Amgen Inc
NASDAQ:AMGN
142B USD 4.4 33.5 16 30.5
US
Gilead Sciences Inc
NASDAQ:GILD
115B USD 4.1 915.4 10.2 10.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
101.6B USD 9.5 -213.4 21 21.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6 -472.7 -514.8 -501.1
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7 31.8 19.7 24.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD 5.6 16.6 15.1 17
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
36B EUR 19.3 -134.7 -108.8 -79.8
P/S Multiple
Revenue Growth P/S to Growth
CN
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Average P/S: 3 457 240.6
7.8
57%
0.1
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.5
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
CN
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Average P/E: 181.7
31.8
73%
0.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61.1
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.5
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
915.4
77%
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -213.4
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -134.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Average EV/EBITDA: 16.5
18.5
99%
0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 476 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -108.8 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Average EV/EBIT: 20.9
18.5
25%
0.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 971.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.5
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.9
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.6
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.8 N/A N/A

See Also

Discover More
Back to Top